{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:25:44Z","timestamp":1790983544742,"version":"4.1.0"},"reference-count":44,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001114","name":"Endocrine Society of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001114","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Health and Medical Research Council Investigator","award":["APP1194576"],"award-info":[{"award-number":["APP1194576"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Primary aldosteronism (PA) is the most common cause of endocrine hypertension. While elevated serum PTH levels have been associated with PA, the extent and nature of this relationship across the broader spectrum of renin-independent aldosteronism remain unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This study aims to elucidate the relationship between PTH and aldosterone excess across the spectrum of renin-independent aldosteronism.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design, Setting, Participants<\/jats:title>\n                  <jats:p>Adults screened for PA who also had a PTH measurement were retrospectively identified from the Monash Health Endocrine Hypertension Clinic (n = 462). Based on the aldosterone-to-renin ratio and results of the saline suppression test where applicable, patients were categorized into 3 groups: PA, low renin without PA, and non-PA. The association between PTH and PA status was evaluated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Serum PTH concentration.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>PTH levels were higher in patients with PA compared to low renin without PA and non-PA (median 5.7 vs 5.3 vs 5.1\u2005pmol\/L respectively, P &amp;lt; .05) despite comparable calcium and kidney function. Twenty-four-hour urinary calcium excretion increased progressively across the spectrum of renin suppression (4.1 vs 4.3 vs 4.9\u2005mmol\/day in non-PA, low renin without PA, and PA groups respectively, P &amp;lt; .05). Patients with PA were more likely to have elevated PTH with normal serum calcium concentration compared to those without PA (38% vs 28%, P = .010).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Increasing PTH concentration and 24-hour urinary calcium excretion were observed across the spectrum of renin-independent aldosteronism. While PTH remained in the normal range for most patients, PA may be considered in patients with elevated PTH and normal serum calcium concentration.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf151","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T08:47:59Z","timestamp":1741337279000},"page":"e3694-e3700","source":"Crossref","is-referenced-by-count":6,"title":["Changes in PTH Across the Spectrum of Renin-independent Aldosteronism"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4631-9105","authenticated-orcid":false,"given":"Angeline","family":"Ooi","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Nursing and Health Sciences, Monash University , Clayton, VIC 3168 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakim","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Monash Health , Clayton, VIC 3168 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Akram","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology & Metabolism, Hudson Institute of Medical Research , Clayton, VIC 3168 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"Fuller","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Monash Health , Clayton, VIC 3168 ,","place":["Australia"]},{"name":"Centre for Endocrinology & Metabolism, Hudson Institute of Medical Research , Clayton, VIC 3168 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9940-4376","authenticated-orcid":false,"given":"Frances","family":"Milat","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Monash Health , Clayton, VIC 3168 ,","place":["Australia"]},{"name":"Centre for Endocrinology & Metabolism, Hudson Institute of Medical Research , Clayton, VIC 3168 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4620-4976","authenticated-orcid":false,"given":"Jun","family":"Yang","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Nursing and Health Sciences, Monash University , Clayton, VIC 3168 ,","place":["Australia"]},{"name":"Department of Endocrinology, Monash Health , Clayton, VIC 3168 ,","place":["Australia"]},{"name":"Centre for Endocrinology & Metabolism, Hudson Institute of Medical Research , Clayton, VIC 3168 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Libianto","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Monash Health , Clayton, VIC 3168 ,","place":["Australia"]},{"name":"Centre for Endocrinology & Metabolism, Hudson Institute of Medical Research , Clayton, VIC 3168 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"2025101519585644200_dgaf151-B1","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2025101519585644200_dgaf151-B2","first-page":"3","article-title":"Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome","volume":"45","author":"Conn","year":"1955","journal-title":"J Lab Clin Med"},{"issue":"1","key":"2025101519585644200_dgaf151-B3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"2025101519585644200_dgaf151-B4","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2025101519585644200_dgaf151-B5","doi-asserted-by":"crossref","first-page":"597247","DOI":"10.1155\/2015\/597247","article-title":"Treatment of primary aldosteronism and organ protection","volume":"2015","author":"Catena","year":"2015","journal-title":"Int J Endocrinol"},{"issue":"7","key":"2025101519585644200_dgaf151-B6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41371-020-0336-2","article-title":"Primary aldosteronism is a public health issue: challenges and opportunities","volume":"34","author":"Libianto","year":"2020","journal-title":"J Hum Hypertens"},{"issue":"10","key":"2025101519585644200_dgaf151-B7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.31128\/AJGP-05-18-4587","article-title":"Current pattern of primary aldosteronism diagnosis: delayed and complicated","volume":"47","author":"Lim","year":"2018","journal-title":"Aust J Gen Practice"},{"key":"2025101519585644200_dgaf151-B8","doi-asserted-by":"crossref","first-page":"574151","DOI":"10.3389\/fendo.2020.574151","article-title":"Primary aldosteronism and bone metabolism: a systematic review and meta-analysis","volume":"11","author":"Shi","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2025101519585644200_dgaf151-B9","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1210\/jc.2016-3206","article-title":"Primary aldosteronism as a risk factor for vertebral fracture","volume":"102","author":"Notsu","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2025101519585644200_dgaf151-B10","doi-asserted-by":"crossref","first-page":"836529","DOI":"10.1155\/2014\/836529","article-title":"Bone and mineral metabolism in patients with primary aldosteronism","volume":"2014","author":"Petramala","year":"2014","journal-title":"Int J Endocrinol"},{"issue":"2","key":"2025101519585644200_dgaf151-B11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/HJH.0b013e32834f0451","article-title":"Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism","volume":"30","author":"Maniero","year":"2012","journal-title":"J Hypertens"},{"issue":"1","key":"2025101519585644200_dgaf151-B12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.eprac.2021.09.002","article-title":"Association between aldosterone and parathyroid hormone levels in patients with adrenocortical tumors","volume":"28","author":"Zavatta","year":"2022","journal-title":"Endocr Pract"},{"issue":"10","key":"2025101519585644200_dgaf151-B13","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/jbmr.1660","article-title":"Bone involvement in aldosteronism","volume":"27","author":"Salcuni","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2025101519585644200_dgaf151-B14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1530\/EJE-17-0417","article-title":"Primary aldosteronism as a cause of secondary osteoporosis","volume":"177","author":"Salcuni","year":"2017","journal-title":"EJE"},{"issue":"2","key":"2025101519585644200_dgaf151-B15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1210\/jc.2014-3949","article-title":"Aldosterone, parathyroid hormone, and the use of renin-angiotensin-aldosterone system inhibitors: the multi-ethnic study of atherosclerosis","volume":"100","author":"Brown","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 3","key":"2025101519585644200_dgaf151-B16","doi-asserted-by":"crossref","first-page":"271S","DOI":"10.1080\/07315724.2006.10719577","article-title":"Role of dietary sodium in osteoporosis","volume":"25","author":"Heaney","year":"2006","journal-title":"J Am Coll Nutr"},{"issue":"3","key":"2025101519585644200_dgaf151-B17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ki.1982.168","article-title":"Importance of dietary sodium in the hypercalciuria syndrome","volume":"22","author":"Muldowney","year":"1982","journal-title":"Kidney Int"},{"issue":"4","key":"2025101519585644200_dgaf151-B18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3949\/ccjm.88a.20166","article-title":"Our evolving understanding of primary aldosteronism","volume":"88","author":"Mehdi","year":"2021","journal-title":"Cleve Clin J Med"},{"issue":"1","key":"2025101519585644200_dgaf151-B19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"issue":"6","key":"2025101519585644200_dgaf151-B20","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocrine Rev"},{"issue":"5","key":"2025101519585644200_dgaf151-B21","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025101519585644200_dgaf151-B22","doi-asserted-by":"crossref","first-page":"lvac003","DOI":"10.1093\/ejendo\/lvac003","article-title":"Saline suppression to distinguish the primary aldosteronism subtype: a diagnostic study","volume":"188","author":"Hashimura","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2025101519585644200_dgaf151-B23","doi-asserted-by":"crossref","first-page":"lvac002","DOI":"10.1093\/ejendo\/lvac002","article-title":"International multicenter survey on screening and confirmatory testing in primary aldosteronism","volume":"188","author":"Naruse","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2025101519585644200_dgaf151-B24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11906-022-01176-7","article-title":"High prevalence of autonomous aldosterone production in hypertension: how to identify and treat it","volume":"24","author":"Wannachalee","year":"2022","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"2025101519585644200_dgaf151-B25","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1210\/jc.2011-2183","article-title":"Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study","volume":"97","author":"Pilz","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025101519585644200_dgaf151-B26","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/jc.2016-3867","article-title":"Renin phenotypes to characterize vascular disease, autonomous aldosteronism, and mineralocorticoid receptor activity","volume":"102","author":"Hundemer","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025101519585644200_dgaf151-B27","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/HYPERTENSIONAHA.116.08952","article-title":"Continuum of renin-independent aldosteronism in normotension","volume":"69","author":"Baudrand","year":"2017","journal-title":"Hypertension"},{"issue":"9","key":"2025101519585644200_dgaf151-B28","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M17-0882","article-title":"The spectrum of subclinical primary aldosteronism and incident hypertension: a cohort study","volume":"167","author":"Brown","year":"2017","journal-title":"Ann Intern Med"},{"issue":"6","key":"2025101519585644200_dgaf151-B29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1210\/er.2017-00189","article-title":"Genetic causes of functional adrenocortical adenomas","volume":"38","author":"Zennaro","year":"2017","journal-title":"Endocr Rev"},{"issue":"2","key":"2025101519585644200_dgaf151-B30","doi-asserted-by":"crossref","first-page":"E209","DOI":"10.1152\/ajpendo.2001.280.2.E209","article-title":"PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells","volume":"280","author":"Mazzocchi","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"2025101519585644200_dgaf151-B31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/HYPERTENSIONAHA.111.173948","article-title":"Primary hyperparathyroidism with concurrent primary aldosteronism","volume":"58","author":"Maniero","year":"2011","journal-title":"Hypertension"},{"issue":"2","key":"2025101519585644200_dgaf151-B32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/HYPERTENSIONAHA.113.01910","article-title":"Human interventions to characterize novel relationships between the renin\u2013angiotensin\u2013aldosterone system and parathyroid hormone","volume":"63","author":"Brown","year":"2014","journal-title":"Hypertension"},{"issue":"6","key":"2025101519585644200_dgaf151-B33","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/cen.14177","article-title":"The effect of vitamin D treatment on clinical and biochemical outcomes of primary aldosteronism","volume":"92","author":"Ismail","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"2025101519585644200_dgaf151-B34","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00198-013-2399-1","article-title":"Bone health and aldosterone excess","volume":"24","author":"Ceccoli","year":"2013","journal-title":"Osteoporos Int"},{"issue":"9","key":"2025101519585644200_dgaf151-B35","doi-asserted-by":"crossref","first-page":"e230056","DOI":"10.1530\/EC-23-0056","article-title":"Aldosterone-producing adenoma is associated with urolithiasis in primary aldosteronism","volume":"12","author":"Kang","year":"2023","journal-title":"Endocr Connect"},{"issue":"6","key":"2025101519585644200_dgaf151-B36","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1210\/clinem\/dgaa123","article-title":"Disentangling the relationships between the renin-angiotensin-aldosterone system, calcium physiology, and risk for kidney stones","volume":"105","author":"Bayomy","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025101519585644200_dgaf151-B37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.physiol.60.1.179","article-title":"Codependence of renal calcium and sodium transport","volume":"60","author":"Friedman","year":"1998","journal-title":"Annu Rev Physiol"},{"issue":"6 Pt 2","key":"2025101519585644200_dgaf151-B38","first-page":"F941","article-title":"Renal sodium handling in normal humans subjected to low, normal, and extremely high sodium supplies","volume":"249","author":"Roos","year":"1985","journal-title":"Am J Physiol"},{"issue":"4","key":"2025101519585644200_dgaf151-B39","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s42000-020-00195-w","article-title":"Management of parathyroid disorders: recommendations of the working group of the Bone Section of the Hellenic Endocrine Society","volume":"19","author":"Makras","year":"2020","journal-title":"Hormones (Athens)"},{"issue":"4","key":"2025101519585644200_dgaf151-B40","doi-asserted-by":"crossref","first-page":"K47","DOI":"10.1093\/ejendo\/lvae020","article-title":"Moderate salt restriction in primary aldosteronism improves bone metabolism through attenuation of urinary calcium and phosphate losses","volume":"190","author":"Schneider","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2025101519585644200_dgaf151-B41","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s41440-020-0529-7","article-title":"Abdominal aortic calcification is more severe in unilateral primary aldosteronism patients and is associated with elevated aldosterone and parathyroid hormone levels","volume":"43","author":"Tuersun","year":"2020","journal-title":"Hypertens Res"},{"issue":"2","key":"2025101519585644200_dgaf151-B42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/HYPERTENSIONAHA.112.195891","article-title":"Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma","volume":"60","author":"Rossi","year":"2012","journal-title":"Hypertension"},{"issue":"3","key":"2025101519585644200_dgaf151-B43","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/cen.14145","article-title":"Unilateral primary aldosteronism as an independent risk factor for vertebral fracture","volume":"92","author":"Yokomoto-Umakoshi","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2025101519585644200_dgaf151-B44","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2169\/internalmedicine.5282-20","article-title":"Primary aldosteronism with parathyroid hormone elevation: a single-center retrospective study","volume":"60","author":"Kometani","year":"2021","journal-title":"Intern. Med"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf151\/62337717\/dgaf151.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/11\/e3694\/62337717\/dgaf151.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/11\/e3694\/62337717\/dgaf151.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T23:59:09Z","timestamp":1760572749000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/11\/e3694\/8063345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":44,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,3,7]]},"published-print":{"date-parts":[[2025,10,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf151","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,3,7]]}}}